Appendix: panel participants
K. Bruderek, S. Brandau, University Hospital Essen, Otorhinolaryngology, Essen, Germany
I. Shevchenko, V. Umansky, Skin Cancer Unit, German Cancer Research Center, Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
C. Diaz, University of Miami, Miami, FL, USA
D. Riemann, B. Seliger, Martin Luther University Halle, Halle, Germany
A. Martens, H. Zelba, G. Pawelec, Center for Medical Research, University of Tübingen, Tübingen, Germany
M. Tazzari, A. Cova, C. Castelli and L. Rivoltini,
Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
R. Rae, S. Attig, Medizinische Klinik III, Universitätsmedizin Mainz, Mainz, Germany
D. Wycze, P. Rodri, A. Ochoa, Louisiana State University, New Orleans, LA, USA
A.R. Coleman, A. Cazaly, D. Joseph-Pietras, University of Southampton, Southampton, UK
J. Vella, P. Serafini, Dept. of Microbiology and Immunology, University of Miami, Miami, FL, USA
Y.P. De Coana, R. Kiessling, M. Nystrom, Karolinska Institute, Solna, Sweden
P. Rayman, Y. Yang, J. Finke, Cleveland Clinic, Cleveland, OH, USA
G. Winkels, K. Bublitz, Miltenyi Biotec, Bergisch Gladbach, Germany
S.R. Hadrup, M. Idorn, University Hospital Herlev, Herlev, Denmark
C. Alanio, M. Albert, L. Rogge, M. Hasan, Center for Human Immunology, Institut Pasteur, Paris, France
J. Hermes, I. Poschke, DKFZ, Heidelberg, Germany
T. Condamine, D. Gabrilovich, The Wistar Institute, Philadelphia, PA, USA
M.J.P. Welters, V.V. Visconti, J.J. Van Ham, S.H. van der Burg, Leiden University, Leiden, The Netherlands
C. Ma, F. Korangy, T. Greten, NCI, Gastrointestinal Malignancy Section, Bethesda, MD, USA
J. Staats, J. Enzor, Duke CFAR Flow Core Facility, Durham, NC, USA
L.H. Butterfield, M.J. Buffo, University of Pittsburgh Cancer Institute Immunologic Monitoring Lab, Pittsburgh, PA, USA
V. Damuzzo, S. Mandruzzato, University of Padova, Padova, Italy
D. Maurer, S. Walter, Immatics Biotechnologies GmbH, Tübingen, Germany